Therefore, SA reduced the neuron damage by reducing Aβ and inhibiting tau protein hyperphosphorylation, which improved the cognitive ability and mobility of AD mice, especially in the medium concentration treatment. This evidence concerns the gene MAPT and Alzheimer disease.